Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 221 - 230 of 245 for gsk. (0.07 seconds)

CBT 200 Falls 21 Points. More details...
CBT 200 Falls 34 Points. More details...
CBT 200 Books 20 Point Gain. More details...
CBT 200 Scores Second Big Gain In A Row. More details...
Pipeline Has Quantity; But Quality?. More details...
CBT 200 Scores Second Big Gain In A Row. More details...
Transforming Event For Antibiotics Company. More details...
Preoperative Chemo Proves Effective for Fifth Deadliest...
CBT 200 Closes 16 Points Lower. More details...
CBT 200 Rises 11 Points. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital